SCHEMBL25009396

SCHEMBL25009396

COCCNC(=O)c1ccc2nc(-c3ccccc3)c(-c3ccccc3)nc2c1

nearest known ligand 0.77

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.77
KDM4E B2RXH2 5/20 0.77
GAA P10253 4/20 0.77
HPGD P15428 4/20 0.77
POLB P06746 1/20 0.73
TP53 P04637 2/20 0.67
LMNA P02545 1/20 0.67
MEN1 O00255 1/20 0.65
KMT2A Q03164 1/20 0.65
CYP1A2 P05177 1/20 0.65
CYP3A4 P08684 1/20 0.65
CYP2C9 P11712 1/20 0.65
CYP2C19 P33261 1/20 0.65
NAMPT P43490 8/20 0.62
NPSR1 Q6W5P4 1/20 0.61
NPC1 O15118 1/20 0.58
RAB9A P51151 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13410503 0.88 HPGD (0.59) ALDH1A1KDM4EGAAHPGDPOLB
SCHEMBL25009235 0.88 MAPT (0.68) NAMPT
SCHEMBL20467544 0.87 ALDH1A1 (1.00) ALDH1A1KDM4EGAAHPGDPOLB
SCHEMBL20467510 0.86 ALDH1A1 (0.79) ALDH1A1KDM4EGAAHPGDPOLB
SCHEMBL21843716 0.85 ALDH1A1 (0.71) ALDH1A1KDM4EGAAHPGDPOLB
SCHEMBL20467453 0.85 ALDH1A1 (0.86) ALDH1A1KDM4EGAAHPGDPOLB
SCHEMBL20467410 0.84 ALDH1A1 (0.81) ALDH1A1KDM4EGAAHPGDPOLB
SCHEMBL25009417 0.84 ALDH1A1 (0.76) ALDH1A1KDM4EGAAHPGDPOLB
SCHEMBL20467509 0.84 ALDH1A1 (0.84) ALDH1A1KDM4EGAAHPGDPOLB
SCHEMBL25009174 0.82 ALDH1A1 (0.76) ALDH1A1KDM4EGAAHPGDTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230041576-A1 METHODS AND MATERIALS FOR INHIBITING NF-kB ACTIVITY UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2023-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230041576-A1 METHODS AND MATERIALS FOR INHIBITING NF-kB ACTIVITY NFKBIA, IKBKB, NFKB2 ALDH1A1 4286/4885KDM4E 2556/4885GAA 403/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.